Hsiang-Chun Chen
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
-
- Prostate Cancer Treatment and Research 16
- Metastasis and carcinoma case studies 4
- Gastric Cancer Management and Outcomes 4
- Oncology 13
- PARP inhibition in cancer therapy 13
- Co-authors
- Karim Fizazi (13 shared papers)Fred Saad (9 shared papers)Cynthia G. Healy (10 shared papers)Johann S. de Bono (10 shared papers)Akos Czibere (5 shared papers)Celestia S. Higano (5 shared papers)Consuelo Buttigliero (6 shared papers)Niven Mehra (9 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Blood (2 papers)Clinical Cancer Research (1 paper)Gastroenterology (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Hsiang-Chun Chen
30 papers receiving 549 citations
Hsiang-Chun Chen's Hit Papers
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 434
- Oncology 313
- Cancer Research 135
- Molecular Biology 209
- Radiology, Nuclear Medicine and Imaging 67
Countries citing papers authored by Hsiang-Chun Chen
This map shows the geographic impact of Hsiang-Chun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiang-Chun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiang-Chun Chen more than expected).
Fields of papers citing papers by Hsiang-Chun Chen
This network shows the impact of papers produced by Hsiang-Chun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiang-Chun Chen. The network helps show where Hsiang-Chun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsiang-Chun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 192 | |
| 2 | Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial Hit paper breakdown → | 2021 | 183 |
| 3 | 2020 | 34 | |
| 4 | 2022 | 20 | |
| 5 | 2023 | 19 | |
| 6 | 2020 | 16 | |
| 7 | 2022 | 11 | |
| 8 | 2019 | 10 | |
| 9 | 2020 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2018 | 7 | |
| 12 | 2016 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2015 | 4 | |
| 15 | 2015 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2016 | 2 | |
| 20 | 2022 | 2 |
About Hsiang-Chun Chen
Hsiang-Chun Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Surgery, having authored 34 papers that have together received 554 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), PARP inhibition in cancer therapy (13 papers), Cancer Genomics and Diagnostics (5 papers), Metastasis and carcinoma case studies (4 papers), Gastric Cancer Management and Outcomes (4 papers), Gaze Tracking and Assistive Technology (2 papers), Acute Myeloid Leukemia Research (2 papers) and Memory Processes and Influences (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (434 citations), Oncology (313 citations), Cancer Research (135 citations), Molecular Biology (209 citations) and Radiology, Nuclear Medicine and Imaging (67 citations). Hsiang-Chun Chen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Karim Fizazi, Fred Saad, Cynthia G. Healy, Johann S. de Bono, Akos Czibere, Celestia S. Higano, Consuelo Buttigliero, Niven Mehra, Marielena Mata and Patricia Troncoso. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Gastroenterology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.